About this trial
This study includes patients suffering from both sleep apnea and insomnia. All participants receive treatment with CPAP. Half of the participants additionally receive a digital program to treat insomnia, initiated at the same time as CPAP. The other half follows usual care and will be able to access the program after 6 months. The aim is to determine whether treating insomnia earlier improves CPAP use and overall health.
Eligibility criteria
Qualifiers
45-65 years of age
Diagnosis of OSAS by respiratory polygraphy or polysomnography with an apnea-hypopnea index (AHI) ≥20 when scored by PSG or ≥15 when scored by PG30 with a prescription for CPAP therapy
Diagnosis of chronic insomnia according to the International Classification of Sleep Disorders (ICSD 3-TR).31
Ability to communicate in French
Disqualifiers
Current treatment for OSAS
Current or past treatment for chronic insomnia (CBT-I)
Severe restless legs syndrome
REM sleep behaviour disorder
Trial design
Treatments tested in this trial
- digital CBT-I
- CPAP